MedTrace Logo

Neostigmine and Dexamethasone in Adductor Canal Block

NCT04565301 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2022-07-29

No results posted yet for this study

Summary

To compare between the efficacy of neostigmine and dexamethasone as an adjuvant to bupivacaine in adductor canal block after knee arthroscopy surgery.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Dexamethasone

adductor canal block

DRUG

neostigmine

adductor canal block

OTHER

NaCl solutions

adductor canal block

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Heba Omar · associate professor of anesthesia and surgical ICU, faculty of medicine, Cairo university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-20
Primary Completion
2022-07-27
Completion
2022-07-27

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04565301 on ClinicalTrials.gov